Should You Buy MYCELX Technologies Corporation (LON:MYX) Now?

By
Simply Wall St
Published
June 14, 2018
AIM:MYX

MYCELX Technologies Corporation (LON:MYX), a commercial services company based in United States, led the AIM gainers with a relatively large price hike in the past couple of weeks. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Today I will analyse the most recent data on MYCELX Technologies’s outlook and valuation to see if the opportunity still exists. Check out our latest analysis for MYCELX Technologies

What is MYCELX Technologies worth?

According to my valuation model, the stock is currently overvalued by about 54.52%, trading at UK£1.25 compared to my intrinsic value of £0.81. This means that the opportunity to buy MYCELX Technologies at a good price has disappeared! Another thing to keep in mind is that MYCELX Technologies’s share price is quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again.

What kind of growth will MYCELX Technologies generate?

AIM:MYX Future Profit June 14th 18
AIM:MYX Future Profit June 14th 18
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 100.00% over the next year, the near-term future seems bright for MYCELX Technologies. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? It seems like the market has well and truly priced in MYX’s positive outlook, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe MYX should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on MYX for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there’s no upside from mispricing. However, the optimistic prospect is encouraging for MYX, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on MYCELX Technologies. You can find everything you need to know about MYCELX Technologies in the latest infographic research report. If you are no longer interested in MYCELX Technologies, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Simply Wall St character - Warren

Simply Wall St

Simply Wall St is a financial technology startup focused on providing unbiased, high-quality research coverage on every listed company in the world. Our research team consists of equity analysts with a public, market-beating track record. Learn more about the team behind Simply Wall St.